UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Increasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996-2013

American journal of public health (1971), 2016-04, Vol.106 (4), p.686-688

2016

Volltextzugriff (PDF)

Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010

JAMA internal medicine, 2014-10, Vol.174 (10), p.1668

2014

Volltextzugriff (PDF)

Guideline Promoting Buprenorphine for Treatment of Chronic Pain: Transformative Yet Underdeveloped

Annals of internal medicine, 2023-03, Vol.176 (3), p.419-420

2023

Volltextzugriff (PDF)

Availability of medical cannabis services by racial, social, and geographic characteristics of neighborhoods in New York: a cross-sectional study

BMC public health, 2022-04, Vol.22 (1), p.671-671, Article 671

2022

Volltextzugriff (PDF)

Perceived access and barriers to care among illicit drug users and hazardous drinkers: findings from the Seek, Test, Treat, and Retain data harmonization initiative (STTR)

BMC public health, 2018-03, Vol.18 (1), p.366-11, Article 366

2018

Volltextzugriff (PDF)

Time to End Racial Disparities in Buprenorphine Access

American journal of public health (1971), 2023-10, Vol.113 (10), p.1083-1085

2023

Volltextzugriff (PDF)

“I Kicked the Hard Way. I Got Incarcerated.” Withdrawal from Methadone During Incarceration and Subsequent Aversion to Medication Assisted Treatments

Journal of substance abuse treatment, 2016-03, Vol.62, p.49-54

2016

Volltextzugriff (PDF)

Illicit buprenorphine use, interest in and access to buprenorphine treatment among syringe exchange participants

Journal of substance abuse treatment, 2015-01, Vol.48 (1), p.112-116

2015

Volltextzugriff (PDF)

Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs

Addiction science & clinical practice, 2021-10, Vol.16 (1), p.64-10, Article 64

2021

Volltextzugriff (PDF)

Medical Marijuana and Opioids (MEMO) Study: protocol of a longitudinal cohort study to examine if medical cannabis reduces opioid use among adults with chronic pain

BMJ open, 2020-12, Vol.10 (12), p.e043400-e043400

2020

Volltextzugriff (PDF)

Primary care engagement is associated with increased pharmacotherapy prescribing for alcohol use disorder (AUD)

Addiction science & clinical practice, 2019-05, Vol.14 (1), p.19-19, Article 19

2019

Volltextzugriff (PDF)

HIV outcomes among migrants from low-income and middle-income countries living in high-income countries: a review of recent evidence

Current opinion in infectious diseases, 2018-02, Vol.31 (1), p.25-32

2018

Volltextzugriff (PDF)

Factors affecting willingness to provide buprenorphine treatment

Journal of substance abuse treatment, 2009-04, Vol.36 (3), p.244-251

2009

Volltextzugriff (PDF)

Substance use stigma: Reliability and validity of a theory-based scale for substance-using populations

Drug and alcohol dependence, 2016-05, Vol.162, p.34-43

2016

Volltextzugriff (PDF)

"It doesn't make any sense to even try": the disruptive impact of COVID-19's first wave on people with chronic pain using medical cannabis in New York

Journal of cannabis research, 2023-03, Vol.5 (1), p.10-10, Article 10

2023

Volltextzugriff (PDF)

Incarceration history and opioid use among adults living with HIV and chronic pain: a secondary analysis of a prospective cohort study

Health & justice, 2024-05, Vol.12 (1), p.24-9, Article 24

2024

Volltextzugriff (PDF)

Preferences for implementation of HIV pre-exposure prophylaxis (PrEP): Results from a survey of primary care providers

Preventive medicine reports, 2020-03, Vol.17, p.101012-101012, Article 101012

2020

Volltextzugriff (PDF)

COVID-19: The Worst Days of Our Careers

Annals of internal medicine, 2020-06, Vol.172 (11), p.764-765

2020

Volltextzugriff (PDF)

Development and evaluation of a community-based buprenorphine treatment intervention

Harm reduction journal, 2017-05, Vol.14 (1), p.23-23, Article 23

2017

Volltextzugriff (PDF)

Coronavirus Disease 2019 (COVID-19) Disparities: A Call for Equity in Health Outcomes and Clinical Research

Clinical infectious diseases, 2021-12, Vol.73 (11), p.e4139-e4140

2021

Volltextzugriff (PDF)

Opioid Taper Is Associated with Subsequent Termination of Care: a Retrospective Cohort Study

Journal of general internal medicine : JGIM, 2020-01, Vol.35 (1), p.36-42

2020

Volltextzugriff (PDF)

Smoking cessation treatment among office-based buprenorphine treatment patients

Journal of substance abuse treatment, 2014-08, Vol.47 (2), p.175-179

2014

Volltextzugriff (PDF)

Methadone dosing at New York State opioid treatment programs following initial revisions to federal regulations

Drug and alcohol dependence, 2024-05, Vol.258, p.111283-111283, Article 111283

2024

Volltextzugriff (PDF)

A Cross-Sectional Online Survey of HIV Pre-Exposure Prophylaxis Adoption Among Primary Care Physicians

Journal of general internal medicine : JGIM, 2017-01, Vol.32 (1), p.62-70

2017

Volltextzugriff (PDF)

Neuropsychological function is improved among opioid dependent adults who adhere to opiate agonist treatment with buprenorphine-naloxone: a preliminary study

Substance abuse treatment, prevention and policy, 2017-11, Vol.12 (1), p.48-48, Article 48

2017

Volltextzugriff (PDF)

1 – 25 von 166

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(150)
Mit Volltextzugriff
(116)

Publikationsform

Sprache

Englisch
(166)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(139)
Science & Technology
(139)
Humans
(119)
Female
(87)
Male
(82)
Adult
(73)
Hiv
(67)
Middle Aged
(65)
Substance Abuse
(57)
Human Immunodeficiency Virus
(54)
Buprenorphine
(41)
Public, Environmental & Occupational Health
(40)
Buprenorphine - Therapeutic Use
(33)
Opioid-Related Disorders - Drug Therapy
(33)
Narcotics
(32)
Opioids
(31)
Infectious Diseases
(29)
Patients
(29)
Social Sciences
(28)
General & Internal Medicine
(27)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Increasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996-2013

Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010

Guideline Promoting Buprenorphine for Treatment of Chronic Pain: Transformative Yet Underdeveloped

Availability of medical cannabis services by racial, social, and geographic characteristics of neighborhoods in New York: a cross-sectional study

Perceived access and barriers to care among illicit drug users and hazardous drinkers: findings from the Seek, Test, Treat, and Retain data harmonization initiative (STTR)

Time to End Racial Disparities in Buprenorphine Access

“I Kicked the Hard Way. I Got Incarcerated.” Withdrawal from Methadone During Incarceration and Subsequent Aversion to Medication Assisted Treatments

Illicit buprenorphine use, interest in and access to buprenorphine treatment among syringe exchange participants

Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs

Medical Marijuana and Opioids (MEMO) Study: protocol of a longitudinal cohort study to examine if medical cannabis reduces opioid use among adults with chronic pain

Primary care engagement is associated with increased pharmacotherapy prescribing for alcohol use disorder (AUD)

HIV outcomes among migrants from low-income and middle-income countries living in high-income countries: a review of recent evidence

Factors affecting willingness to provide buprenorphine treatment

Substance use stigma: Reliability and validity of a theory-based scale for substance-using populations

"It doesn't make any sense to even try": the disruptive impact of COVID-19's first wave on people with chronic pain using medical cannabis in New York

Incarceration history and opioid use among adults living with HIV and chronic pain: a secondary analysis of a prospective cohort study

Preferences for implementation of HIV pre-exposure prophylaxis (PrEP): Results from a survey of primary care providers

COVID-19: The Worst Days of Our Careers

Development and evaluation of a community-based buprenorphine treatment intervention

Coronavirus Disease 2019 (COVID-19) Disparities: A Call for Equity in Health Outcomes and Clinical Research

Opioid Taper Is Associated with Subsequent Termination of Care: a Retrospective Cohort Study

Smoking cessation treatment among office-based buprenorphine treatment patients

Methadone dosing at New York State opioid treatment programs following initial revisions to federal regulations

A Cross-Sectional Online Survey of HIV Pre-Exposure Prophylaxis Adoption Among Primary Care Physicians

Neuropsychological function is improved among opioid dependent adults who adhere to opiate agonist treatment with buprenorphine-naloxone: a preliminary study

Suchergebnisse filtern